OncoImmunology

Aims & Scope

Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance.

This high-profile journal, OncoImmunology specifically deals with tumor immunology.

Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies.

There is also an ever-growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors.

To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands.

As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies.

There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.

OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology.

Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome.

OncoImmunology publishes Original Research Articles, Brief Reports, Reviews, Commentaries and Meeting Reports in these area of research.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	6.3

SJR (SCImago Journal Rank)

Year	Value
2024	2.542

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	124

Journal Rank

Year	Value
2024	925

Journal Citation Indicator

Year	Value
2024	3440

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• OncoImmunology

  Citation: 1

  Authors:

---